Nordimet

Nordimet is a medicine used to treat the following inflammatory conditions: - active rheumatoid arthritis, a disease causing inflammation in joints; - severe juvenile idiopathic arthritis (JIA), a joint disease in children, when medicines known as NSAIDs (non-steroidal anti-inflammatory drugs) have not worked well enough; - plaque psoriasis (a disease causing red, scaly patches on the skin) in adults with moderate to severe disease who can be treated with a medicine given by mouth or injection; - severe psoriatic arthritis, inflammation of the joints that occurs in patients with psoriasis; - Crohn's disease (a disease causing inflammation of the gut) in adults. It can be used in combination with corticosteroids or on its own to induce or maintain remission (a period without disease symptoms after treatment). Nordimet contains the active substance methotrexate. Nordimet is a ‘hybrid medicine’. This means that it is similar to a ‘reference medicine’ containing the same active substance, but Nordimet is available in more strengths. The reference medicine for Nordimet is Lantarel FS.